Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Polaryx Therapeutics, Inc.
PLYX
Return on equity
Return on equity at other companies
BioMarin Pharmaceuticals
BMRN
9.1%
+2.8pp
Zevra Therapeutics, Inc.
ZVRA
34.8%
+31.3pp
Eton Pharmaceuticals, Inc.
ETON
-34.2%
+0.9pp
PVL
Palvella Therapeutics
PVLA
-34.2%
—
XER
Xeris Biopharma Holdings, Inc.
XERS
-209.8%
—
Relay Therapeutics, Inc.
RLAY
-36.8%
-6.3pp
Other financials
Income statement
See full
Operating income
-$2.0M
+61.2%
Net income
-$2.5M
+49.6%
EPS (diluted)
-$0.05
+54.5%
Balance sheet
See full
Cash & equivalents
$3.1M
+1,132%
Total equity
$2.5M
-41.5%
Total assets
$3.5M
—
Cash flow
See full
Operating cash flow
-$2.1M
-191%
Valuation
See full
Market cap
$111.66M
-89.5%
Returns & leverage
See full
Current ratio
3.5×
—
Watchlist
Screener
Filings
Earnings
Charts